Table 1 Characteristics of ALL patients... | American Society of Hematology

Table 1

Characteristics of ALL patients in the test (HSJ) and validation (DFCI) cohorts

Characteristic	HSJ		DFCI
Characteristic	n	Frequency, %	n	Frequency, %
Sex
Female	142	44.7	123	46.1
Male	176	55.3	144	53.9
Age, y
≥ 1 < 9.99	256	80.5	220	82.4
≥ 10	62	19.5	47	17.6
WBCs, × 10⁹/L
< 50	263	82.6	216	80.9
> 50	55	17.4	51	19.1
Cell type
B	291	91.6	244	92.1
T	27	8.4	21	7.9
Risk group
Standard	153	48.1	165	61.8
High	165	51.9	102	38.2
Treatment protocol
87-01	29	9.1
91-01	63	19.8
95-01	114	35.8	91	34.1
2000-01	112	35.2	176	65.9
Event
Yes	52	16.4	51	19.1
No	266	83.6	216	80.9
Total	318	100	267	100

Characteristic	HSJ		DFCI
Characteristic	n	Frequency, %	n	Frequency, %
Sex
Female	142	44.7	123	46.1
Male	176	55.3	144	53.9
Age, y
≥ 1 < 9.99	256	80.5	220	82.4
≥ 10	62	19.5	47	17.6
WBCs, × 10⁹/L
< 50	263	82.6	216	80.9
> 50	55	17.4	51	19.1
Cell type
B	291	91.6	244	92.1
T	27	8.4	21	7.9
Risk group
Standard	153	48.1	165	61.8
High	165	51.9	102	38.2
Treatment protocol
87-01	29	9.1
91-01	63	19.8
95-01	114	35.8	91	34.1
2000-01	112	35.2	176	65.9
Event
Yes	52	16.4	51	19.1
No	266	83.6	216	80.9
Total	318	100	267	100

Characteristics are shown for white patients of both cohorts.